Title: Discovery and structure-activity relationship of potent and selective covalent inhibitors of transglutaminase 2 for Huntington's disease.
Journal: Journal of medicinal chemistry 20120209
351-83-7
25620-46-6
519004-35-4
519004-34-3
6273-94-5
1153543-03-3
59868-50-7 | Methyl 2-(4-methoxy-4-oxobutanamido)benzoate | AA00ELFU | MFCD00091086
63417-81-2 | 5-(Chloromethyl)-3-(2-thienyl)-1,2,4-oxadiazole | AA00ELRM | MFCD03407322
6052-66-0 | alpha-Ethenylbenzeneethanol | AA00EN0Z | MFCD21232170
58863-48-2 | 3-Bromo-2-methylbenzofuran | AA00EORV | MFCD11111717
59641-25-7 | 2-chloro-3-pyrrolidino-1,4-naphthoquinone | AA00EQQA | MFCD00010368
5699-91-2 | 1,4-Diazaspiro[5.5]undecane-3,5-dione | AA00ESOL | MFCD07688003
6324-87-4 | 2-(2,5-dioxopyrrolidin-3-yl)acetic acid | AA00EVA2 | MFCD09036137
566914-00-9 | IL-1R Antagonist | AA00EYVI | MFCD06411423
56658-35-6 | 2-(3,3-Dimethyl-2-oxobutyl)-1h-isoindole-1,3(2h)-dione | AA00F0B0 | MFCD01934804
59737-33-6 | 3-Morpholinopropanehydrazide | AA00F2EN | MFCD01838567